of borderline significanceP = .07
Controlled extracranial disease ( P = .027) and concomitant systemic therapy ( P = .033) were significantly correlated with longer survival; cumulative intracranial tumor volume and the Karnofsky performance status (KPS) were of borderline significance ( P = .07 and P = .09).